mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.06 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |